Dave Lashmet is the editor of Stansberry Technology, an advisory service focused on the most important trend in the world-emerging technologies. He also serves as a senior analyst and contributor to Stanberry's Investment Advisory, the firm's flagship newsletter on the most promising emerging trends and most influential economic forces affecting the market. Lashmet is known for utilizing an intensive approach to discover under-the-radar technology, biotechnology, and medical companies with catalysts for short-term growth. He has spent a decade teaching and writing about medicine and technology at major research universities such as Harvard Medical School, MIT, Johns Hopkins, and the Centers for Disease Control, to name a few.
EARLY CAREER